NeuroCycle Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

NeuroCycle Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $720,182 in total, most recently in 2019.

neurocycletherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

NeuroCycle Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Employees (self-reported, 2019)5

What does NeuroCycle Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $720,182 in total (2019). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Neurological Disorders and Stroke.

Frequently asked questions about NeuroCycle Therapeutics

Where is NeuroCycle Therapeutics headquartered?

NeuroCycle Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does NeuroCycle Therapeutics do?

NeuroCycle Therapeutics, Inc. is a biotechnology company.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences